Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: Role of prostanoids and calcium mobilization

Vascular Pharmacology

Volumn 40, Issue 1, 2003, Pages 67-76

  Xavier, Fabiano E ^a   Davel, Ana Paula C ^a   Rossoni, Luciana V ^a   Vassallo, Dalton V ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Calcium mobilization; Diabetes; Nitric oxide; Phenylephrine; Prostanoids

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; CALCIUM ION; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROSTAGLANDIN H2; PROSTANOID; STREPTOZOCIN; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CALCIUM; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PHENYLEPHRINE; PROSTAGLANDINS; RATS; RATS, WISTAR; TIME FACTORS; VASOCONSTRICTION;

EID: 0037250719     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00315-4     Document Type: Article

References (37)

1. Abebe W., MacLeod K.M. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can. J. Physiol. Pharmacol. 69:1990;335-361.
2. Abebe W., MacLeod K.M. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Br. J. Pharmacol. 101:1990;465-471.
3. 1-adrenoreceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovasc. Pharmacol. 16:1990;239-248.
4. Bhardway R., Moore P.K. Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J. Pharm. Pharmacol. 40:1988;739-742.
5. Calver A., Collier J., Vallarice P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90:1992;2548-2554.
6. Chang K.S.K., Stevens W.C. Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br. J. Pharmacol. 107:1992;983-990.
7. 2+ and tension in mesenteric arteries from diabetic rats. Br. J. Pharmacol. 134:2001;179-187. (h).
8. Cosentino F., Lüscher T.F. Endothelial dysfunction in diabetes mellitus. J. Cardiovasc. Pharmacol. 32(Suppl. 3):1998;S54-S61.
9. Davel A.P.C., Rossoni L.V., Vassallo D.V. Effects of ouabain on the pressor response to phenylephrine and on the sodium pump activity in diabetic rats. Eur. J. Pharmacol. 406:2000;419-427.
10. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130:2000;963-974.
11. Fitzgerald S.M., Brands M.W. Nitric oxide may be required to prevent hypertension at the onset of diabetes. Am. J. Physiol. 279:2000;E762-E768.
12. Fortes Z.B., Garcia J.L., Scivoletto R. Vascular reactivity in diabetes mellitus: role of the endothelial cells. Br. J. Pharmacol. 79:1983;771-781.
13. Furman B.L., Sneddon P. Endothelium-dependent vasodilator responses of the isolated mesenteric bed are preserved in long-term streptozotocin diabetic rats. Eur. J. Pharmacol. 232:1993;29-34.
14. Garcia M.J., McNamara P.M., Gordon T., Kannell W.B. Morbidity and mortality in diabetes in the Framingham population. Diabetes. 23:1974;105-111.
15. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11259-11263.
16. Heygate K.M., Lawrence I.G., Bennett M.A., Thurston H. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br. J. Pharmacol. 116:1995;3251-3259.
17. Horowitz A., Menice C.B., Laporte R., Morgan K.G. Mechanisms of smooth muscle contraction. Physiol. Rev. 76(4):1996;967-1003.
18. Inazu M., Sakai Y., Homma I. Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur. J. Pharmacol. 203:1991;79-84.
19. Kakkar R., Mantha S.V., Kalra J., Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin. Sci. 91:1996;441-448.
20. 2 involved? Cardiovasc. Res. 24(9):1990;707-710.
21. Miranda F.J., Alabadí J.Á., Lloréns S., Apodaca R.F.R., Centeno J.M., Alborch E. Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine. Eur. J. Pharmacol. 401:2000;397-402.
22. Mulhern M., Docherty J.R. Effect of experimental diabetes on the responsiveness of rat aorta. Br. J. Pharmacol. 97:1989;1007-1012.
23. +ATPase in the aorta. Diabetes. 40:1991;1560-1563.
24. Oyama Y., Kawasaki H., Hattori Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 131:1986;75-78.
25. Özçelikay A.T., Tay A., Güner S., Tasyaran V., Yildizoglu-Ari N., Dinçer D., Altan V.M. Reversal effects of L-arginine treatment on blood pressure and vascular responsiveness of streptozotocin-diabetic rats. Pharmacol. Res. 41:2000;201-209.
26. Peredo H., Agostini M.D., Gimeno M.F., Borda E.S. Hypersensitivity to norepinephrine in vasa deferentia from diabetic rats. Possible participation of metabolic products of arachidonic acid. Prostaglandins Leukot. Med. 15(2):1984;229-239.
27. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 42:1999;204-213.
28. Pieper G.M., Gross G.J.P. Oxygen-derived free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 255:1988;H825-H833.
29. Quilley J., McGiff J.C. Renal vascular responsiveness to arachidonic acid in experimental diabetes. Br. J. Pharmacol. 100(2):1990;336-340.
30. Ramanadham S., Lyness W.H., Tenner T.E. Alteration in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can. J. Physiol. Pharmacol. 62:1984;418-423.
31. Tabernero A., Giraldo J., Vila E. Modeling the changes due the endothelium and hypertension in the α-adrenoreceptor-mediated response of the rat aorta. J. Auton. Pharmacol. 19:1999;219-228.
32. Taylor P.D., Beryl B., Thomas C.R., Poston L. Prevention by insulin treatment of endothelial dysfunction but not enhanced noradrenaline-induced contractility in mesenteric resistance arteries from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 111:1994;35-41.
33. Tesfamariam B. Free radical in diabetic endothelial cell dysfunction. Free Radic. Biol. Med. 16(3):1994;383-391.
34. 2. Am. J. Physiol. 257:1989;H1327-H1333.
35. Tesfamariam B., Brown M.L., Deykin D., Cohen R.A. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J. Clin. Invest. 85:1990;929-932.
36. White R.E., Carrier G.O. Supersensitivity and endothelium dependency of histamine-induced relaxation in mesenteric arteries of diabetic rats. Pharmacology. 33(1):1986;34-38.
37. White R.E., Carrier G.O. Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J. Pharmacol. Exp. Ther. 253:1990;1057-1062.